Castor Maritime Inc. Announces Compliance with Nasdaq Minimum Bid Price Requirement
LIMASSOL, Cyprus, April 15, 2024 (GLOBE NEWSWIRE) — Castor Maritime Inc. (NASDAQ: CTRM), (“Castor”, or the “Company”), a diversified global […]
WalkMe Cements Category Leadership with Continued AI Innovation, Industry Recognition, and Financial Growth
SAN FRANCISCO, April 15, 2024 (GLOBE NEWSWIRE) — WalkMe Ltd. (NASDAQ: WKME), a leading provider of digital adoption solutions, today […]
Verizon Frontline to showcase mission-critical communications solutions at FDIC International 2024
INDIANAPOLIS, April 15, 2024 (GLOBE NEWSWIRE) — The 2024 Fire Department Instructors Conference International kicks off today at the Indiana […]
BOS to Release Financial Results for the First Quarter of 2024 and Host a Video Conference Call on May 30, 2024
RISHON LEZION, Israel, April 15, 2024 (GLOBE NEWSWIRE) — B.O.S. Better Online Solutions Ltd. (“BOS” or the “Company”) (NASDAQ: BOSC), announced […]
LPL Financial Welcomes Advisor Philip Nation
SAN DIEGO, April 15, 2024 (GLOBE NEWSWIRE) — LPL Financial LLC announced today that financial advisor Philip Nation, CFP®, ChFC™, […]
Nova LifeStyle Announces Fiscal 2023 Results
LOS ANGELES, April 15, 2024 (GLOBE NEWSWIRE) — Nova LifeStyle, Inc. (NASDAQ: NVFY) (“Nova LifeStyle” or the “Company”) today announced financial […]
Kratos Defense & Security Solutions, Inc. Completes Development of the Zeus Solid Rocket Motor (SRM) Family with the Successful Zeus 2 Static Test Fire
SAN DIEGO, April 15, 2024 (GLOBE NEWSWIRE) — Kratos Defense & Security Solutions, Inc. (Nasdaq: KTOS), a technology company in […]
Mobile-health Network Solutions Makes History as First APAC Telehealth Company Listed on US Stock Exchange
SINGAPORE, April 15, 2024 (GLOBE NEWSWIRE) — Mobile-health Network Solutions (Nasdaq: MNDR), a pioneering Asia-Pacific (APAC) telehealth provider, celebrates its […]
Reviva Announces FDA Alignment on Brilaroxazine Clinical Trials for NDA in Schizophrenia
– FDA acceptance of 4-week global registrational Phase 3 RECOVER-2 study – – Two positive 4-week studies plus a 12-month […]
Atossa Therapeutics and Quantum Leap Healthcare Announce I-SPY 2 Clinical Trial to Evaluate (Z)-Endoxifen in Combination with Abemaciclib (VERZENIO®) in Women with ER+/HER2- Breast Cancer
SEATTLE, April 15, 2024 (GLOBE NEWSWIRE) — Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”) and Quantum Leap Healthcare […]
